China SXT Pharmaceuticals, Inc.
SXTC
$2.86
$0.3714.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -401.30K | -401.30K | 3.30M | 3.30M | -4.85M |
| Total Depreciation and Amortization | 34.30K | 34.30K | 50.20K | 50.20K | 51.40K |
| Total Amortization of Deferred Charges | 44.20K | 44.20K | 40.00K | 40.00K | 106.40K |
| Total Other Non-Cash Items | 17.40K | 17.40K | -3.71M | -3.71M | 4.24M |
| Change in Net Operating Assets | -373.20K | -373.20K | -348.70K | -348.70K | 157.90K |
| Cash from Operations | -678.60K | -678.60K | -674.20K | -674.20K | -289.80K |
| Capital Expenditure | -- | -- | -3.50K | -3.50K | -- |
| Sale of Property, Plant, and Equipment | 20.30K | 20.30K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 6.90K | 6.90K | 9.80K |
| Cash from Investing | 20.30K | 20.30K | 3.40K | 3.40K | 9.80K |
| Total Debt Issued | 3.69M | 3.69M | 686.20K | 686.20K | 62.40K |
| Total Debt Repaid | -39.10K | -39.10K | 287.60K | 287.60K | -2.29M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -33.80K | -33.80K | -55.20K | -55.20K | -- |
| Cash from Financing | 3.62M | 3.62M | 918.70K | 918.70K | -2.23M |
| Foreign Exchange rate Adjustments | 257.50K | 257.50K | 58.30K | 58.30K | -440.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.22M | 3.22M | 306.10K | 306.10K | -2.95M |
